CHD three-lens brief
Evidence-based stock research on CHD. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -2.54% yesterday. · Underperforming SPY by 12.4pp over 30 days.
- Moved -2.54% yesterday.
- Underperforming SPY by 12.4pp over 30 days.
- Debt-to-equity of 56.8 — balance-sheet-heavy.
CHD closed at $93.58 (-2.54%) as of 2026-05-04. Market cap: $22.17B. P/E (trailing) 30.8. Concerns: moved -2.54% yesterday.; underperforming SPY by 12.4pp over 30 days.. Last quarter: Revenue $1.47B, net income $216.30M, free cash flow $1.13B.
Why three lenses on CHD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CHDacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CHD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CHD brief"></iframe>